Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Patterns and Characteristics of Patients Prescribed Opdivo Qvantig by Early Adopters

NCT07636863 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.

NCT NCT07636863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07636863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Patterns and Characteristics of Patients Prescribed Opdivo Qvantig by Early Adopters
Lead sponsor
Bristol-Myers Squibb
Phase
Observational
Overall status
Completed
Start date
August 21, 2025
Completion date
March 27, 2026
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer